Hypoxia promotes airway differentiation in the human lung epithelium.

Summary

Using human tissue-derived organoids, the authors show that hypoxia drives airway differentiation and suppresses alveolar fate in human lung epithelium through HIF activity. HIF1α/HIF2α differentially regulate lineage decisions, with KLF4/KLF5 identified as direct HIF targets promoting basal and secretory cell fates. Hypoxia also converts fetal and adult AT2 cells into airway, including aberrant basal-like cells seen in fibrosis.

Key Findings

• Hypoxia promotes airway differentiation and suppresses alveolar differentiation in human lung epithelial organoids.
• Airway fate under hypoxia requires HIF activity; HIF1α and HIF2α differentially regulate lineage choices.
• KLF4 and KLF5 are direct HIF targets that promote basal and secretory cell fates.
• Hypoxia converts fetal and adult AT2 cells to airway lineages, including aberrant basal-like cells seen in fibrotic lungs.

Clinical Implications

Understanding hypoxia-HIF-driven epithelial plasticity suggests that modulating oxygenation or HIF signaling could mitigate maladaptive airway metaplasia in fibrotic or hypoxic lung diseases and guide regenerative strategies.

Limitations

• Findings are largely from in vitro organoid systems without in vivo human interventional validation
• Clinical contexts and thresholds of hypoxia that trigger reprogramming remain to be defined

Future Directions

Define hypoxia thresholds and microenvironmental cues in diseased lungs that elicit HIF-driven metaplasia; test pharmacologic HIF modulation to prevent aberrant airway conversion in fibrosis models.